Skip to content
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Radiology

Breast Fibrosis Lump After Biopsy: What Should I Do?

At a Glance

A breast lump may remain after a benign biopsy because the biopsy samples only part of it or healing leaves swelling or scar tissue. If it grows or changes, contact your clinician promptly for an exam, new imaging, and possible repeat sampling.

If you had a biopsy that showed benign (non-cancerous) breast fibrosis, but the lump is still there, growing, or changing, it requires a clear clinical reassessment. A benign biopsy result is reassuring only when the sampled tissue adequately explains the abnormal imaging or the lump felt during an exam [1]. When a changing lump no longer matches that benign diagnosis, doctors use a step-by-step pathway to double-check the area.

What to Do Now

When to Seek Prompt Clinical Review
Contact the clinic that performed your biopsy or your doctor if you notice any changes to the lump. Do not wait for your next routine screening appointment.

When to Seek Urgent Medical Care
Seek immediate or same-day medical attention if you experience signs of a post-biopsy complication or infection, such as:

  • Rapidly expanding swelling
  • Uncontrolled bleeding from the biopsy site
  • Spreading redness, severe warmth, or pus
  • Fever or chills
  • Severe or rapidly worsening pain

Why Benign Lumps Persist

It is common for a stable lump to remain palpable (able to be felt) for weeks or months after a benign biopsy. A core needle biopsy only removes small samples of the tissue, not the entire lump. In addition, the biopsy procedure itself can cause localized changes, such as a hematoma (a collection of blood) or internal scar tissue, which can temporarily make the area feel firm.

However, expected post-biopsy changes should generally be stable or gradually improve. There is a distinct difference between a stable benign lump and one that is progressively growing or changing.

Signs That Require Reassessment

If your biopsy was benign but you notice any of the following changes, you should prompt a clinical review [2]:

  • Enlargement: The mass is noticeably growing larger over time.
  • Texture changes: The area feels significantly firmer, harder, or is now fixed (stuck) to the surrounding skin or chest wall.
  • Skin or nipple changes: You notice new skin dimpling, thickening, redness, or the nipple turning inward (nipple retraction) [3][4].
  • Discharge: Spontaneous, one-sided nipple discharge, especially if it is bloody or clear and sticky (serous discharge) [5][6].
  • New pain: While breast pain alone is usually low risk, new or focal pain accompanied by a changing mass requires combined evaluation [7][8].

The Clinical Reassessment Pathway

If your lump is changing, your care team will not simply rely on the past benign biopsy. They will initiate a step-by-step reassessment to investigate [9].

1. Repeat Clinical Breast Exam

Your doctor will physically examine the lump to assess its size, firmness, and mobility, comparing these current findings to prior examinations.

2. Targeted Imaging

To see what is happening inside the breast, you will likely undergo new imaging. The imaging choice depends on your age, whether you are pregnant or breastfeeding, and the specific clinical findings [10][11]:

  • Under age 30: Targeted ultrasound is generally the first step, as it is highly effective at evaluating specific palpable changes [12].
  • Ages 30 to 39: Your doctor will individualize the approach, often using a combination of ultrasound and diagnostic mammography (or 3D mammography).
  • Age 40 and older: Diagnostic mammography is typically the initial test, often with targeted ultrasound added to help characterize the lump [10][13].

Your radiologist will directly compare these new images to your pre-biopsy scans to objectively measure any growth. (If you go to a new clinic, be sure to bring your previous imaging and pathology reports).

3. Checking for “Concordance”

One of the most important concepts in breast health is radiologic-pathologic concordance. This means the tissue diagnosis (pathology) is a reasonable and adequate explanation for what the scan shows (radiology) and what the doctor feels (clinical exam) [1][14].

If new imaging or clinical exams show highly suspicious features, but the previous biopsy only showed general “fibrosis,” this is considered a discordant result [1]. A discordant result means the team cannot yet be confident that the biopsy explains the finding—it could be a sampling error (the needle missed the main target), a different benign cause, or a missed lesion. When findings are discordant, a benign result does not end the evaluation [15]. Conversely, if the repeat imaging shows only expected post-biopsy changes and is fully concordant with a benign result, your doctor may safely recommend returning to routine screening or a short-interval follow-up.

Even if a repeat scan looks benign, a physical lump that feels highly suspicious on clinical exam remains discordant and requires further testing [16].

4. Further Tissue Sampling

If the findings are progressive, highly suspicious, or discordant, your care team will recommend an individualized approach to get a more definitive answer [15][17]:

  • Repeat Core Needle or Vacuum-Assisted Biopsy (VAB): VAB uses a specialized needle to remove larger tissue samples than a standard biopsy, making it an effective option for double-checking discordant lesions [18][19].
  • Excisional Biopsy: If needle biopsies cannot definitively explain a growing, suspicious mass, or if image-guided biopsy is technically difficult, surgical removal of the area is often recommended [20][21]. An excisional biopsy is a diagnostic procedure to examine the entire tissue; it does not automatically mean that cancer has been found [17].

Trusting your body and speaking up about persistent changes ensures your medical team can accurately distinguish expected healing from issues that require a closer look.

Common questions in this guide

Can a breast lump remain after a benign biopsy?
Yes. A core needle biopsy removes samples rather than the entire lump, and a blood collection or healing scar can make the area feel firm for weeks or months. A lump that is stable or gradually improving may reflect healing, but growth or new changes should be reviewed.
What should I do if the lump grows after a benign breast biopsy?
Contact the clinic that performed the biopsy or your doctor for prompt reassessment rather than waiting for routine screening. The evaluation may include a breast exam, targeted imaging, comparison with earlier scans, and sometimes another tissue sample.
What does radiologic-pathologic concordance mean after a benign breast biopsy?
Radiologic-pathologic concordance means the biopsy result adequately explains the imaging finding and the lump felt on examination. If a mass is changing or looks suspicious but the biopsy only shows fibrosis, the result may be discordant, so a benign report may not end the evaluation.
What tests might be needed for a persistent or growing breast lump?
Your doctor may order targeted ultrasound, diagnostic mammography, or both based on your age and circumstances, then compare the images with pre-biopsy scans. If the findings are progressive, suspicious, or discordant, a repeat core biopsy, vacuum-assisted biopsy, or excisional biopsy may be considered.
When is a breast biopsy complication an emergency?
Seek immediate or same-day medical care for rapidly expanding swelling, uncontrolled bleeding, spreading redness or warmth, pus, fever or chills, or severe or worsening pain. These can signal bleeding or infection and should not wait for routine follow-up.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Are my current physical symptoms and imaging findings considered 'concordant' with my past benign biopsy result?
  2. 2.Could this growth be an expected post-biopsy change like a hematoma, or does it look like something that requires a new sample?
  3. 3.Has my care team directly compared my newest imaging to the scans taken before my biopsy?
  4. 4.If the imaging is benign but the lump still feels suspicious to you, what is our next step for reassessment?
  5. 5.If we need another biopsy, what are the differences between a repeat core biopsy, a vacuum-assisted biopsy, and an excisional biopsy in my specific case?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Radiologic-Pathologic Discordance After Image-Guided Breast Biopsy: A Systematic Review of Prevalence and Outcomes.

    Yincharoen P, Sharma CP, Tawanwongsri W

    Medical sciences (Basel, Switzerland) 2026; (14(2)) doi:10.3390/medsci14020229.

    PMID: 42201021
  2. 2

    Common Breast Problems.

    Salzman B, Collins E, Hersh L

    American family physician 2019; (99(8)):505-514.

    PMID: 30990294
  3. 3

    Mammography Findings of Male Breast Diseases.

    Şafak KY

    The journal of breast health 2015; (11(3)):106-110 doi:10.5152/tjbh.2015.2565.

    PMID: 28331703
  4. 4

    Immune pathogenesis of idiopathic granulomatous mastitis: from etiology toward therapeutic approaches.

    Wang X, He X, Liu J, et al.

    Frontiers in immunology 2024; (15()):1295759 doi:10.3389/fimmu.2024.1295759.

    PMID: 38529282
  5. 5

    Breast imaging in patients with nipple discharge.

    de Paula IB, Campos AM

    Radiologia brasileira 2017; (50(6)):383-388 doi:10.1590/0100-3984.2016.0103.

    PMID: 29307929
  6. 6

    Triple Assessment in the Clinical Evaluation of Ductal Breast Disease.

    Sultana F, Aziz SR, Ara I, et al.

    Mymensingh medical journal : MMJ 2026; (35(2)):602-607.

    PMID: 41914117
  7. 7

    Likelihood of breast cancer among women presenting with breast-related symptoms in primary care, with a focus on isolated mastalgia: a retrospective cohort study.

    van Ieperen SKL, van de Laar FA, Akkermans RP, A Uijen A

    BMC primary care 2026; (27(1)).

    PMID: 42104316
  8. 8

    Assessing and managing benign breast lesions leading to mastalgia: A review of 840 patients.

    Doğan Y, Dede AM, Çapar M, et al.

    Turkish journal of surgery 2025; (41(2)):160-167 doi:10.47717/turkjsurg.2025.6451.

    PMID: 40452176
  9. 9

    [Exploring a non-inflammatory clinical breast mass: Clinical practice guidelines].

    Legendre G, Guilhen N, Nadeau C, et al.

    Journal de gynecologie, obstetrique et biologie de la reproduction 2015; (44(10)):904-12.

    PMID: 26541562
  10. 10

    ACR Appropriateness Criteria Palpable Breast Masses.

    Harvey JA, Mahoney MC, Newell MS, et al.

    Journal of the American College of Radiology : JACR 2016; (13(11S)):e31-e42 doi:10.1016/j.jacr.2016.09.022.

    PMID: 27814822
  11. 11

    ACR Appropriateness Criteria® Palpable Breast Masses.

    , Moy L, Heller SL, et al.

    Journal of the American College of Radiology : JACR 2017; (14(5S)):S203-S224 doi:10.1016/j.jacr.2017.02.033.

    PMID: 28473077
  12. 12

    New Palpable Breast Lump With Recent Negative Mammogram: Is Repeat Mammography Necessary?

    Leung SE, Ben-Nachum I, Kornecki A

    AJR. American journal of roentgenology 2016; (207(1)):200-4 doi:10.2214/AJR.15.14799.

    PMID: 27081707
  13. 13

    Clinical Value of Mammography in the Evaluation of Palpable Breast Lumps in Women 30 Years Old and Older.

    Brown AL, Phillips J, Slanetz PJ, et al.

    AJR. American journal of roentgenology 2017; (209(4)):935-942 doi:10.2214/AJR.16.17088.

    PMID: 28777649
  14. 14

    Impact of multidisciplinary radiologic-pathologic correlation conference for benign image-guided breast biopsies on discordance rates and patient outcomes in a community teaching hospital.

    Olayinka O, Kaur G, Agarwal R, et al.

    Annals of diagnostic pathology 2022; (57()):151864 doi:10.1016/j.anndiagpath.2021.151864.

    PMID: 34972038
  15. 15

    Ultrasonography-guided 14-gauge core biopsy of the breast: results of 7 years of experience.

    Jung I, Kim MJ, Moon HJ, et al.

    Ultrasonography (Seoul, Korea) 2018; (37(1)):55-62 doi:10.14366/usg.17028.

    PMID: 28641365
  16. 16

    Triple assessment breast clinics: The value of clinical core biopsies.

    Maha R, Alison J, Michael S, Manvydas V

    Irish journal of medical science 2024; (193(2)):565-570 doi:10.1007/s11845-023-03445-z.

    PMID: 37550600
  17. 17

    Institutional Review of BI-RADS 5 and BI-RADS 4C Lesions Over 5 Years Following Surgical Excision: Analysis of Radiology-Pathology Correlation.

    Brodsky JE, Ly M, Jang S, et al.

    Journal of breast imaging 2026; (8(5)):540-549 doi:10.1093/jbi/wbag019.

    PMID: 42479170
  18. 18

    Role of ultrasound-guided vacuum-assisted breast biopsy in the management of radiologic-pathologic discordance: a retrospective single-centre study.

    Vatteroni G, Pinna G, Trimboli RM, et al.

    La Radiologia medica 2024; (129(10)):1454-1462 doi:10.1007/s11547-024-01864-1.

    PMID: 39102107
  19. 19

    The Evolving Role of Vacuum Assisted Biopsy of the Breast: A Progression from Fine-Needle Aspiration Biopsy.

    Bennett IC, Saboo A

    World journal of surgery 2019; (43(4)):1054-1061 doi:10.1007/s00268-018-04892-x.

    PMID: 30617562
  20. 20

    Troubleshooting to Overcome Technical Challenges in Image-guided Breast Biopsy.

    Chesebro AL, Chikarmane SA, Ritner JA, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2017; (37(3)):705-718 doi:10.1148/rg.2017160117.

    PMID: 28410063
  21. 21

    Pathologic High-risk Lesions, Diagnosis and Management.

    Murray M

    Clinical obstetrics and gynecology 2016; (59(4)):727-732 doi:10.1097/GRF.0000000000000234.

    PMID: 27681693

This page is for informational purposes only and does not constitute medical advice. A breast lump that persists or grows after a benign biopsy should be assessed by your clinician, especially if you notice new warning signs.

Get notified when new evidence is published on breast fibrosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.